Byung-Woo Yoon Selected Research

Ischemic Stroke

3/2024	The impact of statin treatment duration on the risk of new-onset diabetes mellitus and recurrent vascular events in ischemic stroke patients: a linked data analysis.
1/2024	Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial.
10/2023	U-shaped associations between glycated albumin and obesity and role of IL-10 in hyperacute ischemic stroke.
9/2023	Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke.
1/2023	Association of high-estimated glomerular filtration rate with the severity of ischemic stroke during non-vitamin K antagonist oral anticoagulants therapy: a nationwide cohort study.
1/2023	Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosis.
1/2022	Effects of Dose Titration on Dipyridamole-Induced Headache: A Randomized, Double-Blind Clinical Trial.
1/2022	2022 Update of the Korean Clinical Practice Guidelines for Stroke: Antithrombotic Therapy for Patients with Acute Ischemic Stroke or Transient Ischemic Attack.
3/2021	Glycated Albumin, a Novel Biomarker for Short-Term Functional Outcomes in Acute Ischemic Stroke.
2/2021	Personalized Consideration of Admission-Glucose Gap between Estimated Average and Initial Glucose Levels on Short-Term Stroke Outcome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Byung-Woo Yoon Research Topics

Disease

61	Stroke (Strokes) 05/2024 - 06/2006
41	Ischemic Stroke 03/2024 - 09/2008
13	Cerebral Hemorrhage 01/2022 - 12/2002
12	Brain Ischemia (Cerebral Ischemia) 02/2016 - 09/2004
10	Hemorrhage 01/2024 - 10/2005
9	Infarction (Infarctions) 09/2020 - 11/2002
8	Ischemia 01/2015 - 11/2002
7	Atrial Fibrillation 01/2023 - 05/2015
6	Atherosclerosis 02/2023 - 02/2014
6	Embolic Stroke 08/2022 - 09/2016
6	Transient Ischemic Attack 01/2022 - 01/2007
5	Hematoma 01/2022 - 06/2006
4	Brain Infarction 01/2024 - 01/2007
4	Embolism (Embolus) 01/2022 - 05/2014
4	Neoplasms (Cancer) 02/2021 - 11/2016
4	Brain Injuries (Brain Injury) 12/2018 - 05/2010
4	Inflammation (Inflammations) 02/2016 - 04/2009
4	Hemorrhagic Stroke 01/2016 - 06/2010
3	Thrombosis (Thrombus) 01/2024 - 05/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 09/2010
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2017 - 09/2008
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2011 - 11/2009
3	Hypertension (High Blood Pressure) 05/2010 - 12/2002
2	Headache (Headaches) 01/2022 - 06/2011
2	Cerebral Small Vessel Diseases 01/2022 - 02/2014
2	Cerebral Infarction 10/2021 - 01/2015
2	Hyperglycemia 02/2021 - 09/2003
2	Pathologic Constriction (Stenosis) 06/2018 - 06/2010
2	Chronic Renal Insufficiency 03/2017 - 06/2014
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2016 - 12/2008
2	Abscess 06/2015 - 07/2012
2	Wounds and Injuries (Trauma) 06/2015 - 01/2005
2	Atherosclerotic Plaque (Atheroma) 02/2014 - 01/2012
2	Brain Edema (Cerebral Edema) 01/2014 - 09/2008
2	Tuberculosis (Tuberculoses) 07/2012 - 09/2008
2	Infections 09/2008 - 03/2002
1	Diabetes Mellitus 03/2024
1	Factor XI Deficiency (Hemophilia C) 01/2024
1	Obesity 10/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2022
1	Genetic Risk Score 01/2021

Drug/Important Bio-Agent (IBA)

9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2022 - 09/2008
8	AnticoagulantsIBA 01/2023 - 10/2005
7	RivaroxabanIBA 08/2022 - 09/2016
6	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2012
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 12/2008
5	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 02/2014
5	Angiotensin Receptor AntagonistsIBA 12/2018 - 09/2008
4	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 12/2008
3	AlbuminsIBA 10/2023 - 01/2015
3	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 09/2016
3	Dipyridamole (Persantine)FDA LinkGeneric 01/2022 - 09/2008
3	Indicators and Reagents (Reagents)IBA 02/2021 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 12/2018 - 09/2004
3	fimasartanIBA 12/2018 - 01/2015
3	C-Reactive ProteinIBA 01/2018 - 02/2011
3	Warfarin (Coumadin)FDA LinkGeneric 10/2017 - 09/2013
3	Heparin (Liquaemin)FDA LinkGeneric 01/2016 - 06/2006
3	Clopidogrel (Plavix)FDA Link 01/2016 - 09/2008
3	LipidsIBA 02/2014 - 12/2002
3	CholesterolIBA 06/2010 - 12/2002
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2023 - 01/2023
2	CreatinineIBA 01/2023 - 06/2014
2	Nicardipine (Dagan)FDA LinkGeneric 01/2022 - 01/2016
2	Triglycerides (Triacylglycerol)IBA 10/2021 - 09/2010
2	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2019
2	Calcibiotic Root Canal SealerIBA 12/2018 - 09/2014
2	Factor Xa InhibitorsIBA 06/2018 - 09/2016
2	Oxygen (Dioxygen)IBA 11/2017 - 01/2016
2	Cystatin CIBA 03/2017 - 06/2014
2	ORALIT (ORS)IBA 01/2015 - 12/2012
2	LeptinIBA 06/2013 - 01/2012
2	Telmisartan (Micardis)FDA Link 10/2008 - 09/2008
2	Neuroprotective AgentsIBA 10/2008 - 01/2005
2	heat-shock protein 70.1IBA 01/2005 - 09/2004
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2024
1	Factor XIa (Coagulation Factor XIa)IBA 01/2024
1	milvexianIBA 01/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2023
1	Interleukin-10 (Interleukin 10)IBA 10/2023
1	CytokinesIBA 10/2023
1	tyrosine-4-azophenyltrimethylammonium chloride (TAPT)IBA 09/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2023
1	KynurenineIBA 02/2023
1	Lysine (L-Lysine)FDA Link 02/2023
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 02/2023
1	Serine (L-Serine)FDA Link 02/2023
1	PutrescineIBA 02/2023
1	Threonine (L-Threonine)FDA Link 02/2023
1	Vitamin K FDA Link 01/2023
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2023
1	Proton Pump InhibitorsIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2021

Therapy/Procedure

28	Therapeutics 05/2024 - 03/2002
4	Thrombectomy 02/2021 - 01/2017
4	Transplantation 02/2016 - 06/2003
2	Secondary Prevention 01/2018 - 09/2016
1	Duration of Therapy 03/2024
1	Glycemic Control 02/2021
1	Long-Term Care 12/2020